Vericel (VCEL) Other Non Operating Income (2010 - 2026)
Vericel (VCEL) reported Other Non Operating Income of $71000.0 for Q1 2026, up 69.05% on a YoY basis from $42000.0 in Q1 2025, and up 297.22% sequentially from -$36000.0 in Q4 2025.
Vericel (VCEL) Other Non Operating Income (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Other Non Operating Income data on file, last reported at $71000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 69.05% year-over-year to $71000.0; the trailing twelve-month figure through Mar 2026 stood at -$15000.0 (down 106.15% YoY), and the FY2025 full-year result was -$44000.0, down 122.56% from the prior year.
- Other Non Operating Income climbed to $71000.0 in Q1 2026, from -$36000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $140000.0 in Q3 2024 to a low of -$36000.0 in Q4 2025.
- A 5-year average of $22411.8 and a median of -$5000.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income surged 14100.0% in 2024 and slumped 200.0% in 2025, its largest moves.
- Tracing VCEL's Other Non Operating Income over 5 years: stood at -$3000.0 in 2022, then soared by 2833.33% to $82000.0 in 2023, then decreased by 14.63% to $70000.0 in 2024, then tumbled by 151.43% to -$36000.0 in 2025, then soared by 297.22% to $71000.0 in 2026.
- Business Quant data shows VCEL's Other Non Operating Income at $71000.0 in Q1 2026, -$36000.0 in Q4 2025, and -$26000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | -36,000.00 |
| Sep 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | 70,000.00 |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Mar 31, 2023 | -12,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -9,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | -13,000.00 |
| Jun 30, 2021 | -27,000.00 |